Kenneth Lock
Corporate Officer/Principal chez ACELYRIN, INC.
Fortune : 212 795 $ au 31/05/2024
Profil
Kenneth A.
Lock is currently the Chief Commercial Officer at ACELYRIN, Inc. He previously worked as the Executive Director-Sales & Marketing at Gilead Sciences, Inc. from 2013 to 2019, as a Principal at Amgen, Inc. from 2007 to 2013, and as a Principal at IDEC Pharmaceuticals Corp.
He also worked as the Chief Commercial Officer & Senior Vice President at Arcutis Biotherapeutics, Inc. from 2020 to 2023.
Additionally, he earned an MBA from Cornell University and an undergraduate degree from the University of California San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/04/2023 | 25 454 ( 0,02% ) | 212 795 $ | 31/05/2024 |
Postes actifs de Kenneth Lock
| Sociétés | Poste | Début |
|---|---|---|
| ACELYRIN, INC. | Corporate Officer/Principal | 18/07/2023 |
Anciens postes connus de Kenneth Lock
| Sociétés | Poste | Fin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 02/06/2023 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 01/08/2019 |
| AMGEN INC. | Corporate Officer/Principal | 01/11/2013 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Corporate Officer/Principal | 01/02/2007 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Kenneth Lock
| Cornell University | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| ACELYRIN, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
